BASF will showcase its innovations for the pharmaceutical industry at the CPhI worldwide event, which is to be held in Frankfurt, Germany. The company will exhibit a range of pharmaceutical products and services, including inorganic specialties, catalysts, protective groups, reagents, solvents, building blocks, custom synthesis, excipients and APIs.
The company will feature PeroXeal, a new packaging for polyvinylpyrrolidone-based pharmaceutical excipients. The packaging eliminates penetration of atmospheric oxygen, thereby reducing oxidation level. This can lead to a considerable reduction in the peroxide level and make the excipients suitable for application in oxygen-sensitive API formulations. Other benefits of PeroXeal are enhanced formulation, stability of completed pharmaceutical dosages and an extended shelf life of excipients.
The company has also unveiled a new line of high purity iron salts, which is ideal for magnetic resonance imaging, phosphate management and iron deficiency anemia. A key benefit of the new iron salts is that its trace-metal impurities are maintained to a single digit ppm level. The salts are offered in several volumes to meet the requirements of the clients.
BASF will present the N-Methylpyrrolidone (NMP) Life Science solvent grade at the event. It is an ideal alternative to conventional NMP grades. NMP Life Science grade has a lower level of amines, whereas conventional grade contains minimum of ten times more amines. The new grade has low water content of 0.03% or less and it can be recycled frequently than conventional grades.
BASF has acquired Cognis and added high-purity oleochemicals to its pharmaceutical excipients portfolio. The company currently offers a wide range of waxes, dispersions, emollients, solvents, emulsifiers or solubilizers and pharmaceutical-grade ingredients for the dermatology industry.
NanoSelect platform technology from BASF has been used to produce platinum-based catalysts for high nitro group hydrogenation process. The technology is also used to enable production of advanced platinum catalysts for use in halo nitro aromatic hydrogenation activities.